Legal Representation
Attorney
Ronald M. Kachmarik
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 2, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 2, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 21, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 19, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jun 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 9, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 9, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 20, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 20, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 25, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 14, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 14, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Scientific research for medical purposes in the field of pharmaceuticals; pharmaceutical research and development services; Scientific research in the nature of conducting clinical trials to determine the efficacy and safety of pharmaceutical products in the treatment of decompensated liver disease, acute-on-chronic liver failure (ACLF); conducting scientific feasibility studies, including analysis; providing information, including results and data, relating to scientific or medical research in the field of pharmaceuticals and development of pharmaceutical products, especially from an online searchable database; Scientific research in the nature of conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research in the field of hepatic, metabolic, gastrointestinal and oncological diseases and disorders; evaluation of the efficacy of pharmaceutical products; Scientific research in the nature of clinical development services.
Class 044
Advisory services relating to health being medical care; medical information; Providing medical information, namely, compilation of medical reports; medical information services provided via the Internet; medical diagnosis services.
Additional Information
Design Mark
The mark consists of the stylized wording "UNVEIL-IT" in teal blue, with a representation of a liver to the left in teal blue, and a check mark replacing the "V" also in teal blue.
Color Claim
The color(s) teal blue is/are claimed as a feature of the mark.
Pseudo Mark
UNVEIL IT
Classification
International Classes
042
044